Search
A Maryland drug distributor lost $2.7 million in a settlement over selling secondhand medicine to U.S. pharmacies. Additional news in Alabama, California, New Jersey, Tennessee and more.
Read More
United States District Court Northern District of Alabama USA v Sherrie McCain Plea Agreement Filed February 20, 2024 Read the document.
Read More
United States District CourtNorthern District of Alabama USA v Sherrie McCain Information Filed February 20, 2024 Read the document.
Read MoreFreedom of Information Act materials PSM often files federal and state Freedom of Information requests with government agencies to dig into the subjects we research. We post the materials that we receive on this website. If you’re keeping track, you can see all those posts here.
Read More
Companies in New York and Florida were selling unapproved GLP-1 agonists. Operation Shield IV removed $69 million in illicit medicine and doping substances from European markets. A California man who distributed smuggled tianeptine received a two-year sentence.
Read More
PSM opposes the practice of reimbursing pharmacies below the cost of acquisition of medicine and supports efforts to reform reimbursement systems that eliminate this market dynamic that threatens the safety of our drug supply.
Read MoreAnother black market HIV case has been successfully prosecuted.
Read More
The government won prosecutions in Massachusetts and New Hampshire against defendants selling non-FDA approved drugs. A family warns about tianeptine. Pill presses in Texas, Virginia and West Virginia.
Read MoreOn January 31, the Department of Justice (DOJ) announced that eBay had agreed to pay $59 million to settle allegations it had not followed recordkeeping and reporting requirements for the sale of pill presses and encapsulating machines that are specified in the Controlled Substances Act. The $59 million settlement is a signal to other online marketplaces that the federal government…
Read More
“We are deeply concerned about the impact importation of unapproved foreign prescription drugs will have on counterfeit medication in the United States, especially as FDA considers approving additional SIPs.”
Read More